Antifungal activity of essential oils against filamentous fungi determined by broth microdilution and vapour contact methods

Journal of Applied Microbiology ISSN 1364-5072 ORIGINAL ARTICLE Antifungal activity of essential oils against filamentous fungi determined by broth microdilution and vapour contact methods V. Tullio 1, A. Nostro 2, N. Mandras 1, P. Dugo 3, G. Banche 1, M.A. Cannatelli 2, A.M. Cuffini 1, V. Alonzo 2 and N.A. Carlone 1 1 Department of Public Health and Microbiology, University of Turin, Turin, Italy 2 Pharmaco-Biological Department, Faculty of Pharmacy, University of Messina, Messina, Italy 3 Departments of Organic and Biological Chemistry, Faculty of Science, University of Messina, Messina, Italy Keywords: antifungal activity, dermatophytes, essential oils, filamentous fungi, microdilution method, vapour contact method. Correspondence Vivian Tullio, Department of Public Health and Microbiology, University of Turin, Via Santena 9, 10126 Turin, Italy. E-mail: vivian.tullio@unito.it 2006/0197: received 13 February 2006, revised 26 July 2006 and accepted 5 September 2006 doi:10.1111/j.1365-2672.2006.03191.x Abstract Aims: The in vitro activity of some essential oils (EO) (thyme red, fennel, clove, pine, sage, lemon balm and lavender) against clinical and environmental fungal strains was determined. Methods and Results: The minimal inhibitory concentrations were determined by a microdilution method in RPMI 1640 and by a vapour contact assay. The composition of oils was analysed by gas chromatography (GC) and GC/mass spectrometry. The results indicated that the oils antifungal activity depended on the experimental assay used. The inhibiting effects of EO in vapour phase were generally higher than those in liquid state. According to both methods thyme red and clove were found to be the oils with the widest spectrum of activity against all fungi tested. Conclusions: Despite the differences between the two methods, our results demonstrate that some EO are very active on dermatophytes and dematiaceous fungi. However, more data will be necessary to confirm this good in vitro efficacy. Significance and Impact of the Study: This study could identify candidates of EO for developing alternative methods to control environmental and clinically undesirable filamentous fungi. Introduction The increasing recognition and importance of fungal infections, the difficulties encountered in their treatment and the increase in resistance to antifungal agents have stimulated the search for therapeutic alternatives (Pina- Vaz et al. 2004). The essential oils (EO) and products of plant secondary metabolism had a wide application in folk medicine, fragrance industries, food flavouring and preservation but only in recent years they have started to be recognized for their potential antimicrobial role (Kalemba and Kunicka 2003). Although numerous studies have documented the EO antibacterial and anticandidal effect (Inouye et al. 2001a; Oliva et al. 2003; Burt 2004; Chami et al. 2004; Friedman et al. 2004; Hammer et al. 2004), there have been few comprehensive in vitro studies of the effects exerted by EO on filamentous fungi, probably due to the difficulties encountered in standardized susceptibility methods for these mycetes (Hammer et al. 2002, 2003; Koc et al. 2005; Silva et al. 2005). Recently, National Committee for Clinical Laboratory Standards (CLSI) (2002) has approved a method for broth dilution antifungal susceptibility testing of filamentous fungi, including aspergilli, Fusarium spp., Rhizopus arrhizus, Pseudallescheria boydii and Sporothrix schenkii, but not penicilli, dermatophytes and dematiaceous fungi. EO antimicrobial activity in vitro could also be tested using a vapour contact (VC) method; recently, some studies have reported the higher potency of EO in vapour state than that in solution contact (Inouye et al. 2000, 2001b). 1544 Journal compilation ª 2006 The Society for Applied Microbiology, Journal of Applied Microbiology 102 (2007) 1544 1550

V. Tullio et al. Antifungal activity of essential oils The aim of this study was to determine the in vitro activities of seven EO against some environmental and clinically important fungi, i.e. dermatophytes, Zygomycetes, penicilli, aspergilli and dematiaceous moulds, by using two different investigative tools, such as the modified (CLSI) NCCLS method and the VC assay. Materials and methods Essential oils and gas chromatography-flame ionization detector and gas chromatography-mass spectrometry analysis The EO used, purchased from Azienda Agricola Aboca (Sansepolcro, Arezzo), were obtained by steam distillation from Thymus vulgaris L. (thyme red), Foeniculum vulgare Mill. var. dulce DC (fennel), Eugenia caryophyllata Thumb. (clove), Pinus sylvestris L. (pine), Salvia officinalis L. (sage), Melissa officinalis L. (lemon balm) and Lavandula vera DC (lavender). All gas chromatography-flame ionization detector (GC-FID) analyses were carried out with either a Shimadzu GC-2010 gas chromatograph with a split/splitless injector or a Shimadzu autosampler AOC- 20is (Shimadzu, Milan, Italy). In details: column MDN- 5S, 30 m 0Æ25 mm ID 0Æ25 mm film thickness (5% diphenyl + 95% polydimethylsiloxane) (Supelco, Milan, Italy); temperature program, 50 C (2 min) to 250 C (10 min) at 3 C min )1 ; injection temperature, 250 C; injection volume, 1 ml; inlet pressure, 100 kpa; carrier gas, H 2 ; linear velocity (u), 30 cm s )1 ; split ratio, 100 : 1; detector, flame ionization detector at 275 C; H 2 flow, 50 ml min )1 ; air flow, 400 ml min )1 ; make up (N 2 /air), 50 ml min )1 ; sampling rate, 200 ms. All GC-mass spectrometry (MS) analyses were carried out with a Shimadzu GC-MS QP-2010 model GC-MS equipped with an AOC- 20is series autosampler, under the same conditions used for GC-FID analyses. In detail: inlet pressure, 37Æ1 kpa; carrier gas, H 2 ; linear velocity (u), 32Æ4 cms )1 ; split ratio, 50 : 1; detector, MS (250 C); interface T, 250 C; MS mode, EI; detector voltage, 0Æ9 kv; mass range, 40 400 u; scan speed, 769 u s )1 ; interval, 0Æ5 s (2 Hz). All data were acquired by a GC/MS solution software (Shimadzu). The components were identified by comparison of their mass spectra with commercial mass spectral libraries. Fungal isolates A total of 44 strains were used. These included: dermatophytes (Microsporum canis, Microsporum gypseum, Trichophyton mentagrophytes, Epidermophyton floccosum); clinical isolates from onychomycosis (Scopulariopsis brevicaulis, Fusarium oxysporum) and from bronchial alveolar lavage ( niger, flavus, Asp. flavus var. columnaris, fumigatus); environmental strains: Zygomycetes (Mucor spp. and Rhizopus spp.), penicilli (Penicillium lanosum and Penicillium frequentans) and dematiaceous fungi (Alternaria alternata and Cladosporium cladosporioides). Trichophyton mentagrophytes strains were isolated from both human and animal clinical specimens. Human dermatophytes, Scop. brevicaulis and Fus. oxysporum were provided by Clinica Dermatologica II Discipline Medico-Chirurgiche Department, University of Turin, San Lazzaro Hospital (Turin, Italy), whereas aspergilli by A.S.L. San Giovanni Battista-Molinette (Turin); animal strains were provided by Giancarlo Baralis veterinary (Turin). Fungi were identified according to macroscopic and microscopic morphological procedures and maintained on potato dextrose agar (PDA) slopes stored at room temperature. Before the experiments the fungi were transferred to fresh media and incubated for 7 days, in twice. Preparation of non-germinated conidial suspensions Inocula were prepared by growing aspergilli, penicilli and Fus. oxysporum isolates on PDA (Merck, Darmstadt, Germany) slopes as described by the reference method M38-A recommended by the National Committee for Clinical Laboratory Standards (CLSI) (2002). Conversely, dermatophytes, dematiaceous fungi, Scop. brevicaulis and Zygomycetes were incubated on Sabouraud dextrose (SAB; Merck) agar at room temperature for 7 days, except for Zygomycetes (3 days). Slopes were flooded with 0Æ85% saline and conidia gently probed; the resulting suspensions were removed and vortexed thoroughly. After the settling of the larger particles, suspensions were adjusted by nephelometry and diluted in saline to obtain inocula of 2 10 4 CFU ml )1, as confirmed by colony counts in triplicate on SAB agar. Broth microdilution method Broth microdilution (BM) testing was based on National Committee for Clinical Laboratory Standards (CLSI) (2002) method, with some modifications. A volume of 40% (v/v) stock solution of each EO in ethanol (1 : 2Æ5) was diluted 1 : 20 in RPMI-1640 (with l-glutamine and phenol red, without bicarbonate) (Invitrogen, San Giuliano Milanese, Milan, Italy), containing 3-(N-morpholino) propane sulfonic acid (MOPS) (Sigma-Aldrich, Steinheim, Germany) at a concentration of 0Æ165 mol l )1 for ph 7Æ0, to obtain 2% v/v solution. Doubling dilutions of the EO ranging from 2% to 0Æ0038% (v/v) were prepared in 96-well microtitre trays in RPMI-1640 with MOPS. After the addition of 0Æ1 ml of inoculum, the trays were incubated at 30 C for 7 days. Journal compilation ª 2006 The Society for Applied Microbiology, Journal of Applied Microbiology 102 (2007) 1544 1550 1545

Antifungal activity of essential oils V. Tullio et al. The final EO concentrations ranging from 1% to 0Æ0019% (v/v) and ethanol maximum concentration was 1Æ5% (v/v). Growth controls consisting of RPMI-1640 medium and RPMI-1640 with 1Æ5% (v/v) ethanol were included for each isolate tested. The minimal inhibitory concentration (MIC) of EO was defined as the lowest concentration of compound that completely inhibited visible growth after 3 and 7 days of incubation. The minimal fungicidal concentration (MFC) of EO was determined by spot inoculating 10 ll from wells not visibly turbid onto SAB agar plates that were incubated for 3 days at 30 C (Hammer et al. 2002). MFC was defined as the lowest concentration resulting in no growth on subculture. Vapour contact assay The effect of volatile oil fraction was studied with an invert Petri dishes method. Double-strength concentrated RPMI 1640 broth supplemented with l-glutamine, phenol red and MOPS, adjusted to ph 7Æ0 was mixed with molten 3Æ0% (w/v) agar in an equal ratio immediately before the assay. The RPMI agar was poured into a 90 mm Petri dish and spot inoculated with 1 ll of standardized suspension of each fungal strain tested (final concentration of 10 4 conidia per ml). A glass slide (1-cm size) was placed in the cover of each Petri dish, so that it did not directly touch the surface of the agar medium, and various amounts of pure EO were added to obtain final concentration ranging from 1% to 0Æ0019% v/v air space. The space inside of the sealed Petri dish was calculated to be 70 cm 3 air. The plates were sealed with vinyl tape immediately after inoculation, and incubated at 30 C for 7 days. The control, consisting of RPMI medium, was included. The MIC (%, v/v air space) was determined by comparison with the control and was defined as the lowest concentration of EO inhibiting the visible growth. Results The major components of the EO are reported in Table 1. Tables 2 and 3 compare the MICs of the seven EO tested by the two methods used. Using BM method, the MICs values ranged from 0Æ0078% to 0Æ5% after 3 days, and from 0Æ25% to >1% after 7 days for dermatophytes and Scop. brevicaulis; MICs for Fus. oxysporum ranged from 0Æ0156% to 0Æ125% after 3 and 7 days (Table 2). MICs for aspergilli and penicilli ranged from 0Æ125% to 1% after 3 and 7 days, whereas for dematiaceous they ranged from 0Æ0312% to 0Æ5% after 3 days, and from 0Æ125% to 1% after 7 days (Table 3). Zygomycetes showed the lowest susceptibility (MIC 1%) and were not inhibited by any oil. Thyme red was found to be the oil with the better spectrum of activity against all fungi tested, followed by clove and fennel. Among the 44 fungi tested, the most susceptible were dermatophytes, Fus. oxysporum and Pen. frequentans (Table 2), followed by dematiaceous fungi (Table 3). Almost all EO exhibited good antifungal activity, which generally decreased in the following order: thyme, clove, fennel and pine. The pine EO displayed a good activity against dermatophytes and onychomycosis fungi (Table 2). Sage, lemon balm and lavender EO were the weakest in activity against aspergilli (Table 3). A comparison of values obtained at 3 and 7 days showed that EO MICs did not change for Fus. oxysporum, whereas those for aspergilli, penicilli, dermatophytes and Scop. brevicaulis were one or more concentrations higher at 7 days compared with those observed at 3 days. Similarly, MICs obtained with dematiaceous fungi were one or more concentrations higher at 7 days, with the exception of clove and pine EO. By the VC method the MICs were lower than those in liquid medium for five of the seven EO tested. Among Table 1 Essential oils used and their major constituents Essential oil Thyme red Fennel Clove Pine Sage Lemon balm Lavender Major constituents (content) Thymol 26Æ5 Anethone 72Æ1 Eugenol 77Æ5 a-pinene 55Æ7 cis-thujone 29Æ4 Citronellal 25Æ2 Linalool 41Æ9 p-cymene 16Æ2 Fenchone 14Æ2 Eugenyl acetate 7Æ6 b-pinene 10 Camphor 22Æ6 Limonene 12Æ4 Linalyl acetate 32Æ7 Limonene 13Æ2 a-pinene 3Æ7 b-caryophyllene 6Æ8 Limonene 9Æ7 1,8-Cineole 7Æ7 Geranial 8Æ8 Lavandulyl acetate 3Æ2 a-pinene 11Æ5 Methyl chavicol 3Æ7 d-3-carene 6Æ9 a-humulene 5Æ8 a-terpineol 6Æ3 b-caryophyllene 2Æ9 Carvacrol 7Æ8 Limonene 3 Myrcene 3Æ4 Camphene 5Æ4 Geraniol 6Æ3 Terpinen-4-ol 2 c-terpinene 4 trans-thujone 4Æ2 Neral 5Æ4 b-caryophyllene 3Æ5 a-terpinenyl 4Æ5 acetate a-pinene 2Æ7 Isopulegol 4Æ3 Borneol 2Æ2 Citronellol 3Æ5 Limonene 2Æ2 Linalool 2Æ3 Values given are expressed in percentage. 1546 Journal compilation ª 2006 The Society for Applied Microbiology, Journal of Applied Microbiology 102 (2007) 1544 1550

V. Tullio et al. Antifungal activity of essential oils Table 2 Essential oils minimal inhibitory concentration (MIC) values for dermatophytes, Scopulariopsis brevicaulis and Fusarium oxysporum by the broth microdilution (BM) and vapour contact (VC) methods MIC ranges (% v/v) Species (no. strains) Method (days) Thyme Fennel Clove Pine Sage Lemon balm Lavender Microsporum canis (4) BM (3) 0Æ06 0Æ125 0Æ06 0Æ125 0Æ06 0Æ125 0Æ125 0Æ0312 0Æ125 0Æ0625 0Æ125 0Æ0625 0Æ25 BM (7) 0Æ125 0Æ25 0Æ125 0Æ25 0Æ125 0Æ5 0Æ125 0Æ5 0Æ25 1 0Æ125 1 0Æ25 0Æ5 VC (3) 0Æ0078 0Æ0156 0Æ125 0Æ0078 0Æ0312 0Æ0312 0Æ125 0Æ0156 0Æ0625 0Æ0156 0Æ0312 0Æ0156 0Æ0625 VC (7) 0Æ0078 0Æ0156 0Æ0156 0Æ125 0Æ0312 0Æ125 0Æ125 0Æ250 0Æ0625 0Æ250 0Æ0156 0Æ0312 0Æ0312 0Æ125 Microsporum gypseum (6) BM (3) 0Æ0078 0Æ125 0Æ015 0Æ25 0Æ0625 0Æ25 0Æ125 0Æ25 0Æ125 0Æ5 0Æ125 0Æ5 0Æ125 0Æ5 BM (7) 0Æ0625 0Æ125 0Æ125 0Æ25 0Æ125 0Æ25 0Æ25 0Æ5 0Æ5 1 0Æ5 1 0Æ5 1 VC (3) 0Æ0019 0Æ0078 0Æ0156 0Æ0312 0Æ0078 0Æ0312 0Æ125 0Æ0156 0Æ0625 0Æ0156 0Æ0312 0Æ0156 0Æ0312 VC (7) 0Æ0078 0Æ0156 0Æ125 0Æ0156 0Æ0312 0Æ125 0Æ250 0Æ0625 0Æ125 0Æ0156 0Æ0312 Trichophyton mentagrophytes (animal) (2) BM (3) 0Æ25 0Æ25 0Æ25 0Æ25 0Æ5 0Æ25 0Æ0625 BM (7) 0Æ25 0Æ5 0Æ25 0Æ5 1 1 1 VC (3) 0Æ0019 0Æ0078 0Æ0156 0Æ0312 0Æ0039 0Æ0312 0Æ125 0Æ0312 0Æ0156 0Æ0312 VC (7) 0Æ0078 0Æ0625 0Æ0078 0Æ125 0Æ5 0Æ0625 0Æ125 0Æ0156 0Æ0312 0Æ0625 Trichophyton mentagrophytes (human) (3) BM (3) 0Æ0625 0Æ25 0Æ0625 0Æ5 0Æ0625 0Æ25 0Æ125 0Æ25 0Æ125 0Æ25 0Æ25 0Æ5 0Æ0625 0Æ5 BM (7) 0Æ25 0Æ25 0Æ5 0Æ25 0Æ25 0Æ5 0Æ25 0Æ5 0Æ5 1 0Æ5 1 VC (3) 0Æ0039 0Æ0078 0Æ0156 0Æ0078 0Æ0156 0Æ0625 0Æ125 0Æ00156 0Æ0312 0Æ0039 0Æ0078 0Æ0156 0Æ0312 VC (7) 0Æ0039 0Æ0078 0Æ0156 0Æ0312 0Æ0078 0Æ0156 0Æ125 0Æ250 0Æ0312 0Æ0078 0Æ0312 Epidermophyton floccosum (1) BM (3) 0Æ0312 0Æ125 0Æ125 0Æ125 0Æ25 0Æ25 0Æ5 BM (7) 0Æ0625 0Æ125 0Æ25 0Æ125 0Æ25 0Æ25 0Æ5 VC (3) ND* ND ND ND ND ND ND VC (7) ND ND ND ND ND ND ND Scopulariopsis brevicaulis (3) BM (3) 0Æ25 0Æ25 0Æ25 0Æ25 0Æ25 0Æ25 0Æ25 0Æ5 BM (7) 1 1 1 1 1 1 1 VC (3) 0Æ0039 0Æ0078 0Æ0625 0Æ125 0Æ0312 0Æ125 0Æ0625 0Æ250 0Æ0078 0Æ0156 0Æ0078 0Æ0625 VC (7) 0Æ0078 0Æ0625 1 0Æ0312 0Æ125 0Æ0625 1 0Æ125 0Æ5 0Æ0312 0Æ125 Fusarium oxysporum (2) BM (3) 0Æ125 0Æ0625 0Æ0312 0Æ0312 0Æ0156 0Æ0312 0Æ0156 BM (7) 0Æ125 0Æ0625 0Æ0312 0Æ0312 0Æ0156 0Æ0312 0Æ0156 VC (3) 0Æ0078 0Æ25 0Æ0312 >1 0Æ125 0Æ0312 0Æ25 VC (7) 0Æ0156 >1 0Æ0312 >1 0Æ250 0Æ125 0Æ5 *ND, not determined. Journal compilation ª 2006 The Society for Applied Microbiology, Journal of Applied Microbiology 102 (2007) 1544 1550 1547

Antifungal activity of essential oils V. Tullio et al. Table 3 Essential oils minimal inhibitory concentration (MIC) values for filamentous fungi by the broth microdilution (BM) and vapour contact (VC) methods MIC ranges (% v/v) Method Species (no. strains) (days) Thyme Fennel Clove Pine Sage Lemon balm Lavender Mucor spp. (2) BM (3) >1 >1 >1 >1 >1 >1 >1 BM (7) >1 >1 >1 >1 >1 >1 >1 VC (3) 0Æ0156 0Æ250 0Æ0625 0Æ5 0Æ125 0Æ0156 0Æ0625 VC (7) 0Æ0156 0Æ5 0Æ0625 0Æ5 0Æ125 0Æ0312 0Æ125 Rhizopus spp. (2) BM (3) >1 >1 >1 >1 >1 >1 >1 BM (7) >1 >1 >1 >1 >1 >1 >1 VC (3) 0Æ0156 0Æ250 0Æ125 0Æ5 0Æ250 0Æ0312 0Æ125 VC (7) 0Æ0312 0Æ250 0Æ125 0Æ5 0Æ250 0Æ0312 0Æ250 niger (3) flavus (3) flavus var. columnaris (1) fumigatus (4) Penicillium lanosum (2) Penicillium frequentans (2) Alternaria alternata (3) Cladosporium cladosporioides (3) ND, not determined. BM (3) 0Æ125 0Æ25 0Æ25 0Æ25 0Æ25 0Æ5 1 1 1 BM (7) 0Æ25 0Æ5 0Æ25 0Æ25 0Æ5 1 1 1 VC (3) 0Æ0078 0Æ0625 0Æ125 0Æ0625 0Æ125 >1 0Æ125 0Æ250 0Æ0078 0Æ0312 0Æ0625 VC (7) 0Æ0078 0Æ0156 0Æ5 >1 0Æ0625 0Æ125 >1 0Æ250 0Æ5 0Æ0156 0Æ0312 0Æ125 BM (3) 0Æ25 0Æ25 0Æ5 0Æ25 0Æ5 1 0Æ5 0Æ5 1 BM (7) 0Æ25 0Æ5 0Æ25 0Æ5 1 1 1 VC (3) 0Æ0078 0Æ0156 0Æ125 0Æ0625 0Æ125 >1 0Æ250 0Æ0312 0Æ0625 0Æ125 0Æ250 VC (7) 0Æ0156 0Æ0312 0Æ25 >1 0Æ0625 0Æ125 >1 0Æ250 1 0Æ125 0Æ250 BM (3) 0Æ125 0Æ125 0Æ125 0Æ125 0Æ125 0Æ125 0Æ125 BM (7) 0Æ25 0Æ25 0Æ125 0Æ125 >1 >1 >1 VC (3) ND* ND ND ND ND ND ND VC (7) ND ND ND ND ND ND ND BM (3) 0Æ25 0Æ25 0Æ25 0Æ25 1 0Æ5 1 0Æ5 1 0Æ5 1 BM (7) 0Æ25 0Æ5 1 0Æ5 0Æ5 1 0Æ5 1 1 1 VC (3) 0Æ0078 0Æ0156 0Æ0625 0Æ125 0Æ0625 0Æ250 0Æ5 1 0Æ125 0Æ250 0Æ0078 0Æ0312 0Æ0312 0Æ0625 VC (7) 0Æ0078 0Æ0312 0Æ5 >1 0Æ0625 0Æ250 0Æ5 >1 0Æ125 0Æ5 0Æ0312 0Æ0625 0Æ125 0Æ250 BM (3) 0Æ25 0Æ25 0Æ25 0Æ5 1 0Æ25 0Æ5 BM (7) 0Æ25 0Æ5 0Æ25 1 1 1 1 VC (3) 0Æ0156 0Æ00625 0Æ0312 1 0Æ0625 0Æ0156 0Æ0625 VC (7) 0Æ0312 1 0Æ0312 >1 0Æ125 0Æ0312 0Æ0625 BM (3) 0Æ0625 0Æ125 0Æ0625 0Æ125 0Æ25 0Æ125 0Æ125 BM (7) 0Æ25 0Æ25 0Æ125 0Æ5 0Æ5 0Æ5 0Æ5 VC (3) 0Æ0078 0Æ0625 0Æ0156 0Æ5 0Æ0625 0Æ0156 0Æ0312 VC (7) 0Æ0156 0Æ5 0Æ0156 >1 0Æ125 0Æ0156 0Æ0625 BM (3) 0Æ125 0Æ5 0Æ25 0Æ5 0Æ125 0Æ5 0Æ125 0Æ25 0Æ125 0Æ25 0Æ25 1 0Æ0625 0Æ5 BM (7) 0Æ5 0Æ5 0Æ5 0Æ125 0Æ25 0Æ25 1 0Æ5 VC (3) 0Æ0078 0Æ0156 0Æ0625 0Æ0156 0Æ0312 >1 0Æ0625 0Æ0156 0Æ0625 VC (7) 0Æ0078 0Æ125 0Æ250 0Æ0312 0Æ0625 1 0Æ125 0Æ250 0Æ0312 0Æ0625 0Æ250 BM (3) 0Æ0625 0Æ0625 0Æ125 0Æ125 0Æ25 0Æ03 0Æ25 0Æ0625 0Æ25 0Æ03 0Æ25 0Æ015 0Æ25 BM (7) 0Æ125 0Æ25 0Æ25 0Æ125 0Æ25 0Æ125 0Æ25 0Æ125 0Æ5 0Æ25 0Æ5 0Æ25 1 VC (3) 0Æ0078 0Æ0039 0Æ0156 0Æ0312 0Æ0078 0Æ0156 0Æ0312 0Æ125 0Æ0312 0Æ0625 0Æ0078 0Æ0156 0Æ0078 0Æ0156 VC (7) 0Æ0078 0Æ0312 0Æ0625 0Æ0078 0Æ0156 0Æ250 1 0Æ0625 0Æ250 0Æ0156 0Æ0156 0Æ0312 these, thyme red was found to be the oil with the highest activity, followed by lemon balm, clove, lavender and sage. The activity of fennel and pine oils was weaker. Interestingly, Mucor spp. and Rhizopus spp. exhibited susceptibility to all EO vapours whereas they were not susceptible in liquid state (Tables 2 and 3). Table 4 depicts MFC values obtained from BM wells method after 7 days. In general, MFCs were one or more concentrations higher than MICs at 7 days, with some exceptions for dematiaceous fungi and Fus. oxysporum. Discussion Recently, the scientific interest into biological properties of EO has been increasing. In particular, a large number of papers have been published on the EO antimicrobial activity, but many of them focused on the activity of EO in solution against bacteria and yeasts while little investigation on the effect of EO in vapour state has been performed (Inouye et al. 2000, 2001a, 2001b). In the present study, the antifungal activity of seven EO were compared 1548 Journal compilation ª 2006 The Society for Applied Microbiology, Journal of Applied Microbiology 102 (2007) 1544 1550

V. Tullio et al. Antifungal activity of essential oils Table 4 Essential oils minimal fungicidal concentration (MFC) values for dermatophytes and filamentous fungi MFC ranges (% v/v) Species (no. strains) Thyme Fennel Clove Pine Sage Lemon balm Lavender Microsporum canis (4) 0Æ25 0Æ5 0Æ25 0Æ5 0Æ25 1 0Æ25 1 0Æ5to >1 0Æ25 to >1 0Æ5 to >1 Microsporum gypseum (6) 0Æ5 1 0Æ5 1 0Æ25 1 0Æ5 1 >1 1 to >1 1 to >1 Trichophyton mentagrophytes (animal) (2) 0Æ5 1 0Æ5 1 >1 >1 >1 Trichophyton mentagrophytes (human) (3) 0Æ25 0Æ5 0Æ25 1 0Æ5 0Æ25 1 0Æ5 1 1 1 Epidermophyton floccosum (1) 0Æ0625 0Æ25 0Æ25 0Æ25 0Æ25 0Æ25 0Æ5 Scopulariopsis brevicaulis (3) >1 >1 >1 1 >1 >1 >1 Fusarium oxysporum (2) 0Æ125 0Æ125 0Æ0312 0Æ0625 0Æ0625 0Æ0312 0Æ125 niger (3) 0Æ5 0Æ5 0Æ5 1 1 >1 >1 >1 flavus (3) 1 >1 0Æ5 1 1 1 1 flavus var. columnaris (1) 0Æ5 1 0Æ5 0Æ5 ND ND ND fumigatus (4) 1 >1 1 >1 >1 >1 >1 Penicillium lanosum (2) 1 >1 1 >1 >1 >1 >1 Penicillium frequentans (2) 1 >1 0Æ5 0Æ5 1 0Æ5 >1 Alternaria alternata (3) >1 >1 0Æ5 >1 0Æ5 1 to >1 1 Cladosporium cladosporioides (3) 0Æ5 1 0Æ25 0Æ5 0Æ125 0Æ5 0Æ25 0Æ5 1 0Æ25 1 0Æ25 to >1 by microdilution and VC methods against dermatophytes and other moulds. Quantification of the EO antimicrobial activity appears to be influenced by the test method used, as evidenced by the differences between the MICs obtained by BM and VC methods. The results revealed that five of the seven EO tested were stronger inhibitory in vapour state than in liquid phase. The efficacy of EO in vapour state was probably attributable to the direct deposition of EO on lipophilic fungal mycelia together with an indirect effect via adsorption through the agar medium (Inouye et al. 2000). The high antifungal activity of vapours evidenced in this study was in accordance with previous findings (Suhr and Nielsen 2003). Although a comparison of studies with different methodologies is difficult, our data correlate with those of Suhr and Nielsen (2003), who showed that thyme and clove oils were more effective in vapour state against Asp. flavus. The EO are complex mixtures of many different aromatic components with various degrees of lipophilicity and relative hydrophilicity given by the presence of constituents with polar functional groups (Griffin et al. 1999). When added to a medium, the EO distributes more or less into the aqueous phase depending on its relative hydrophilicity. Hence, an EO with constituents with low water solubility should dissolve little in aqueous medium, and consequently should show a weak activity. This is the case of lemon balm and lavender oils whose constituents (linalool, linalyl-acetate and citronellal, limonene respectively) have been reported to possess low water solubility (Griffin et al. 1999). These EO, however, showed very good activity when assayed by VC and this might related to their high volatility (Inouye et al. 2000). These observations suggest that the physical and chemical properties (solubility and volatility) can have considerable effect on the in vitro antimicrobial activity, but it must be pointed out that the intrinsic activity of a compound is of paramount importance for the evaluation of its efficacy. In this context, the EO-containing aldehyde or phenol was reported to exhibit a high inhibitory effect, followed by those containing alcohol, ketone and ether (Dorman and Deans 2000; Inouye et al. 2001a). Hence it is not surprising that thyme and clove oil proved to be the overall best inhibitors because of phenolic thymol, carvacrol and eugenol as the major contributors to their bioactivity. Although thymol and carvacrol possess moderate solubility and low volatility, their vapours have been reported to accumulate in great amounts into agar layers (Inouye et al. 2001a). Chami et al. (2004) reported the high antifungal activity of carvacrol and eugenol on experimental oral candidiasis in immunosuppressed rats and interestingly demonstrated that the fungi disappeared completely from the tongue mucosa in all treated animals whereas many hyphae were found when nystatin was used as control. The EO clinical application is often discouraged because of their potential harsh or caustic effects when used at high concentrations due to their lipophilic character (Inouye et al. 2000). Indeed, it is true that these problems could be partly solved making use of their specific volatility at room temperature. Overall, our results show the higher potency of EO in vapour state than that in solution contact, suggesting that they could have distinct advantages including the reduction of effective dose and potential chemical irritation. Despite the differences between the two methods, our results demonstrate that some EO are very active on dermatophytes and dematiaceous fungi. Similarly, the higher sensibility of dermatophytes was observed by other Authors with other EO (Salgueiro et al. 2004; Cavaleiro Journal compilation ª 2006 The Society for Applied Microbiology, Journal of Applied Microbiology 102 (2007) 1544 1550 1549

Antifungal activity of essential oils V. Tullio et al. et al. 2006). However, more data will be necessary either to confirm this good in vitro efficacy or to explain the EO mechanisms of action. Further studies are required to study the effect and toxicity of these compounds in experimental animals (in vivo) and to establish if they could be safely used as antifungal agents against these fungi. Our findings showing that some EO are effective against Scop. brevicaulis and Fus. oxysporum which are often resistant to available antifungal agents, open important perspectives in alternative antifungal therapies. Moreover, this study could identify candidate EO for developing alternative methods to control environmental undesirable filamentous fungi. Acknowledgements The authors are grateful to Professor O. Cervetti and Dr M. Panzone (Clinica Dermatologica II Department of Discipline Medico-Chirurgiche, University of Turin, Italy), Dr R. Serra (A.S.L. San Giovanni Battista-Molinette, Turin) and Dr Giampiero Baralis for providing fungal strains. References Burt, S. (2004) Essential oils: their antibacterial properties and potential applications in foods a review. Int J Food Microbiol 94, 223 253. Cavaleiro, C., Pinto, E., Gonçalves, M.J. and Salgueiro, L. (2006) Antifungal activity of Juniperus essential oils against dermatophyte, and Candida strains. J Appl Microbiol 100, 1333 1338. Chami, F., Chami, N., Tennis, S., Trouillas, J. and Remmal, A. (2004) Evaluation of carvacrol and eugenol as prophylaxis and treatment of vaginal candidiasis in an immunosuppressed rat model. J Antimicrob Chemother 54, 909 914. Dorman, H.J.D. and Deans, S.G. (2000) Antimicrobial agents from plants: antibacterial activity of plant volatile oils. J Appl Microbiol 88, 308 316. Friedman, M., Henika, P.R., Levin, C.E. and Mandrell, R.E. (2004) Antibacterial activities of plant essential oils and their components against Escherichia coli O157:H7 and Salmonella enterica in apple juice. J Agric Food Chem 52, 6042 6048. Griffin, S.G., Wyllie, S.G., Markham, J.L. and Leach, D. (1999) The role of structure and molecular properties of terpenoids in determining their antimicrobial activity. Flavour Frag J 14, 322 332. Hammer, K.A., Carson, C.F. and Riley, T.V. (2002) In vitro activity of Melaleuca alternifolia (tea tree) oil against dermatophytes and other filamentous fungi. J Antimicrob Chemother 50, 195 199. Hammer, K.A., Carson, C.F. and Riley, T.V. (2003) Antifungal activity of the components of Melaleuca alternifolia (tea tree) oil. J Appl Microbiol 95, 853 860. Hammer, K.A., Carson, C.F. and Riley, T.V. (2004) Antifungal effects of Melaleuca alternifolia (tea tree) oil and its components on Candida albicans, Candida glabrata and Saccharomyces cerevisiae. J Antimicrob Chemother 53, 1081 1085. Inouye, S., Tsuruoka, T., Watanabe, M., Takeo, K., Akao, M., Nishiyama, Y. and Yamaguchi, H. (2000) Inhibitory effect of essential oils on apical growth of fumigatus by vapour contact. Mycoses 43, 17 23. Inouye, S., Takizawa, T. and Yamaguchi, H. (2001a) Antibacterial activity of essential oils and their major constituents against respiratory tract pathogens by gaseous contact. J Antimicrob Chemother 47, 565 573. Inouye, S., Uchida, K. and Yamaguchi, H. (2001b) In-vitro and in-vivo anti-trichophyton activity of essential oils by vapour contact. Mycoses 44, 99 107. Kalemba, D. and Kunicka, A. (2003) Antibacterial and antifungal properties of essential oils. Curr Med Chem 10, 813 829. Koc, A.N., Silici, S., Ayangil, D., Ferahbaş, A. and Cankaya, S. (2005) Comparison of in vitro activities of antifungal drugs and ethanolic extract of propolis against Trichophyton rubrum and T. mentagrophytes by using a microdilution assay. Mycoses 48, 205 210. National Committee for Clinical Laboratory Standards (CLSI) (2002) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi. Approved standard. NCCLS Document M38-A. Wayne, PA, USA: NCCLS. Oliva, B., Piccirilli, E., Ceddia, T., Pontieri, E., Aureli, P. and Ferrini, A.M. (2003) Antimycotic activity of Melaleuca alternifolia essential oil and its components. Lett Appl Microbiol 37, 185 187. Pina-Vaz, C., Gonçalves Rodrigues, A., Pinto, E., Costa-de- Oliveira, S., Tavares, C., Salgueiro, L., Cavaleiro, C., Gonçalves, M.J. et al. (2004) Antifungal activity of Thymus oils and their major compounds. J Eur Acad Dermatol Venereol 18, 73 78. Salgueiro, L., Pinto, E., Gonçalves, M.J., Pina-Vaz, C., Cavaleiro, C., Rodrigues, A.G., Palmeira, A., Tavares, C. et al. (2004) Chemical composition and antifungal activity of the essential oil of Thymbra capitata. Planta Med 70, 572 575. Silva, M.R.R., Oliveira, J.G. Jr, Fernandes, O.F.L., Passos, X.S., Costa, C.R., Souza, L.K.H., Lemos, J.A. and Paula, J.R. (2005) Antifungal activity of Ocimum gratissimum towards dermatophytes. Mycoses 48, 172 175. Suhr, K.I. and Nielsen, P.V. (2003) Antifungal activity of essential oils evaluated by two different application techniques against rye bread spoilage fungi. J Appl Microbiol 94, 665 674. 1550 Journal compilation ª 2006 The Society for Applied Microbiology, Journal of Applied Microbiology 102 (2007) 1544 1550